Explore the benefits of shorter, simpler breast cancer treatments through subcutaneous therapy, enhancing patient comfort and ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral therapy (ART) avoided rebound for 5 months, a randomized trial showed. At ...

With a little planning, you can turn infusion time into an opportunity for rest, creativity, or quiet focus. Infusion therapy often involves spending long periods seated in a chair or bed, with ...

Targeting S100A4 with a monoclonal antibody could comprehensively dampen disease-causing pathways, say drug developers. Calluna Pharma AS, a clinical-stage biotechnology company developing ...

Demand for immunotherapies is climbing, with the global market on track to go from approximately $95 billion at a CAGR of 13.2 percent to an estimated $320 billion by 2033, according to Uniprism ...

BROKEN ARROW, Okla. — A mom in Broken Arrow is fighting a serious lung disease. Kristy Smith says in June she was diagnosed with idiopathic pulmonary fibrosis which caused scarring on the lungs and ...

The exact mechanism responsible for infusion-related reactions (IRRs) after monoclonal antibody (mAb) therapy is unclear. It is also unknown before treatment which patient will develop IRRs. The ...

The dominance of the Delta strain of COVID-19 combined with Alabama’s low vaccination rate has led experts to turn to monoclonal antibody infusion, a treatment in which infected individuals are ...

Myasthenia gravis is a lifelong (chronic) autoimmune condition, which means that the body’s immune system attacks its own healthy cells. Most people with generalized myasthenia gravis (gMG) have ...